log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males
about
Residual macrovascular risk in 2013: what have we learned?eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetesImpaired β cell function in Chinese newly diagnosed type 2 diabetes mellitus with hyperlipidemia.The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea.High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.Impact of serum triglyceride and high density lipoprotein cholesterol levels on early-phase insulin secretion in normoglycemic and prediabetic subjects.Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules.Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adultsClinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride.Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models.Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus.Glycated hemoglobin and associated risk factors in older adults.Estimation of plasma apolipoprotein B concentration using routinely measured lipid biochemical tests in apparently healthy Asian adultsErythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study.The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?Reducing vascular events risk in patients with dyslipidaemia: an update for cliniciansThe atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females.Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DMInverse associations between light-to-moderate alcohol intake and lipid-related indices in patients with diabetesAn association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patientsIncreased burden and severity of metabolic syndrome and arterial stiffness in treatment-naïve HIV+ patients from Cameroon.Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids.Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.Log (TG)/HDL-C ratio as a predictor of decreased islet beta cell function in patients with type 2 diabetes: 6-year cohort study.The mixed benefit of low lipoprotein(a) in type 2 diabetes.Ameliorative Effect of Curcumin on Olanzapine-induced Obesity in Sprague-Dawley Rats.Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired β-cell function.How to transform a metabolic syndrome score into an insulin sensitivity value?Recombinant Incretin-Secreting Microbe Improves Metabolic Dysfunction in High-Fat Diet Fed Rodents.Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance.Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis.
P2860
Q26996039-6235F434-AE34-47FA-B739-CD5B34452380Q28256901-6EAF3BCD-1894-42E6-B343-D709752C1B80Q33563331-AB63F557-8EFC-4D5F-864E-87D0BB18EB07Q33732285-4850692B-C99E-4157-AF69-A90CA1D95C27Q33814212-68FB8FA6-4461-42B7-BB83-A99DF46D219DQ34161905-6CF2B3AB-D6D5-4F5B-A2EF-898443782C02Q34668335-6152450E-0E65-4696-BEA9-63A6ABD93621Q35447178-21B70A7D-5EB0-4313-B57E-58603BC772FDQ35561092-C8BD8242-E141-46C8-B21A-01400C6BC597Q35574009-AC9C28B7-5E96-404D-86D5-3F881C952135Q35579114-BB3DF7DC-02F0-4F04-8E33-48340BAD41D3Q35822331-A9090A0D-E17A-4D0C-9124-E6180D4B85FAQ35999587-E6CCC062-117C-4779-A6DE-B6D943B3DC94Q36092395-4776513E-EC4A-4FAD-8F51-C6B570CF9431Q36281471-C17BB8A8-43C4-4F10-8E93-CA5EDA579638Q36316376-E24A9167-19D1-4DD2-842A-0EB4A27474ECQ36323280-9BCF73C7-216E-4531-91D4-AB117E53E76FQ36411656-5AB0D4CF-6C21-4C10-A5BE-2FCFFD2718DFQ36443768-888B95B5-9272-4845-AEA8-7D2CBDA9A8F2Q36517644-D966300B-51B8-4082-9494-6451ABC258EBQ36697855-B937514A-1949-4E57-80AA-97B72BDCF226Q37045425-C1C612A1-5DBC-497A-8366-F295601E5AD2Q37047629-6679AD63-564E-4427-BBD7-1FE1123D2A33Q37169956-96F27775-51F1-483A-B038-08BBFF7548FCQ37683866-8A6313CA-4DFD-450E-A6D2-F05F1D5AF895Q38872713-A65FA4F3-0071-475D-8C0C-EDB33D0F9E3EQ39111118-67C3A159-94ED-4EAB-AF6E-E68A8F6B584FQ41151540-AB8A34A8-B58D-44E3-96E5-7F68066917B5Q41226651-E753517B-BF7A-4EAD-BA8E-0B6722CB8DCCQ41316289-5795A8AF-5A7B-406C-8B9F-427CD54B3928Q41641381-1716B0FB-BE5D-4C1E-98A4-8E54B4E577B2Q42659870-73281B21-DEC9-4E5C-A9D3-23F716544C1CQ48202771-DFFFAFA3-4F6A-4F43-B17B-6260915561BEQ55235309-ECCF842F-7D69-4690-B364-E0E9A0175FFC
P2860
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
log
@nl
log(TG)/HDL-C is related to bo ...... loss in type 2 diabetes males
@ast
log(TG)/HDL-C is related to bo ...... loss in type 2 diabetes males
@en
type
label
log
@nl
log(TG)/HDL-C is related to bo ...... loss in type 2 diabetes males
@ast
log(TG)/HDL-C is related to bo ...... loss in type 2 diabetes males
@en
prefLabel
log
@nl
log(TG)/HDL-C is related to bo ...... loss in type 2 diabetes males
@ast
log(TG)/HDL-C is related to bo ...... loss in type 2 diabetes males
@en
P2093
P2860
P356
P1476
log(TG)/HDL-C is related to bo ...... loss in type 2 diabetes males
@en
P2093
Michel F Rousseau
Michel P Hermans
Sylvie A Ahn
P2860
P2888
P356
10.1186/1475-2840-9-88
P407
P577
2010-12-14T00:00:00Z
P5875
P6179
1044532747